Wolverine Trading, LLC Vertex Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 8,666 shares of VRTX stock, worth $3.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,666

Previous 2,947 194.06%

Holding current value

$3.44 Million

Previous $1.38 Million 191.82%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $2.63 Million - $2.89 Million	5,719 Added 194.06%	8,666 $4.03 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $4.37 Million - $5.4 Million	-11,124 Reduced 79.06%	2,947 $1.38 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $6.16 Million - $6.74 Million	-15,113 Reduced 51.79%	14,071 $5.88 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $1.53 Million - $1.83 Million	4,458 Added 18.03%	29,184 $11.9 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $5.74 Million - $6.15 Million	16,977 Added 219.09%	24,726 $8.6 Million
Q2 2023 Aug 23, 2023	BUY	$314.42 - $351.91 $58,167 - $65,103	185 Added 2.45%	7,749 $2.73 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $2.14 Million - $2.44 Million	7,564 New	7,564 $2.36 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $437,580 - $488,236	1,598 New	1,598 $468,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $3.35 Million - $3.95 Million	-15,146 Reduced 81.57%	3,423 $878,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $779,198 - $983,626	-4,402 Reduced 19.16%	18,569 $4.13 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $106,657 - $119,358	588 Added 2.63%	22,971 $4.19 Million
Q2 2021 Aug 06, 2021	BUY	$187.49 - $221.1 $1.28 Million - $1.51 Million	6,840 Added 44.01%	22,383 $4.41 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $752,517 - $877,161	-3,635 Reduced 18.95%	15,543 $3.31 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $1.62 Million - $2.15 Million	7,804 Added 68.61%	19,178 $4.46 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $1.18 Million - $1.4 Million	-4,631 Reduced 28.93%	11,374 $3.08 Million
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $589,855 - $773,812	-2,616 Reduced 14.05%	16,005 $4.56 Million
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $1.41 Million - $1.89 Million	8,441 Added 82.92%	18,621 $4.08 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $517,473 - $582,411	-3,113 Reduced 23.42%	10,180 $1.7 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $1.45 Million - $1.64 Million	10,567 Added 387.64%	13,293 $1.99 Million
Q3 2017 Nov 15, 2017	BUY	$148.13 - $162.24 $403,802 - $442,266	2,726	2,726 $414,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Vertex Pharmaceuticals Inc Transaction History